Merosol (1g)


MEROSOL (Meropenem) has a broad spectrum of in vitro activity against Gram-positive and Gram-negative pathogens, including extended-spectrum β-lactamase (ESBL)-and AmpC producing Enterobacteriaceae. MEROSOL has excellent efficacy in cIAI, cSSSI, febrile neutropenia, complicated UTI, obstetric or gynaecological infections and severe CAP, nosocomial pneumonia, cystic fibrosis experiencing acute pulmonary exacerbations, and septicemia. MEROSOL has shown excellent efficacy in pediatric and adult patients with bacterial meningitis.